Percutaneous Coronary Interventions in Facilities without On-Site Cardiac Surgery: A Report from the National Cardiovascular Data Registry (NCDR) ACC/SCAI.

Slides:



Advertisements
Similar presentations
© 2010, American Heart Association. All rights reserved. Are Quality Improvements Associated with the GWTG-Coronary Artery Disease (GWTG-CAD) Program Sustained.
Advertisements

Associations Between Outpatient Heart Failure Process of Care Measures and Mortality Gregg C. Fonarow, Nancy M. Albert, Anne B. Curtis, Mihai Gheorghiade,
Connie N. Hess, MD, Bimal R. Shah, MD, MBA, S. Andrew Peng, MS, Laine Thomas, PhD, Matthew T. Roe, MD, MHS, Eric D. Peterson, MD, MPH Relationship of Early.
V.: 9/7/2007 AC Submit1 Statistical Review of the Observational Studies of Aprotinin Safety Part I: Methods, Mangano and Karkouti Studies CRDAC and DSaRM.
Does Preoperative Hemoglobin Value Predict Postoperative Cardiovascular Complications after Total Joint Arthroplasty? Kishor Gandhi MD, MPH, Eugene Viscusi.
Guidelines recommend consideration of fibrinolytic therapy if unable to achieve a door to balloon time ≤120 minutes for STEMI patients transferred for.
STS 2015 John V. Conte, MD Professor of Surgery Johns Hopkins University School of Medicine On Behalf of the CoreValve US Investigators Transcatheter Aortic.
Clinical Trial Results. org Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent Implantation Eric Eisenstein, DBA; Kevin Anstrom,
The Influence of Radial vs. Femoral Access on Acute Blood Loss in Patients Undergoing Percutaneous Coronary Intervention Amit Nanda 1, Amit P. Amin 2,
Comparison of the New Mayo Clinic Risk Scores and Clinical SYNTAX Score in Predicting Adverse Cardiovascular Outcomes following Percutaneous Coronary Intervention.
The Impact of Intensive Care Unit Structure on Post-operative Outcomes Following Congenital Heart Surgery: Analysis of a Multi-institutional Database Danielle.
Relationship of Time to Treatment and Door-to-Balloon Time to Mortality in Patients with Acute Myocardial Infarction Treated with Primary Angioplasty Christopher.
The Radial Approach to Percutaneous Coronary Intervention Is Associated With a Lower Risk for Complications Regardless of Radial Procedure Volume: A Report.
CPORT- E Trial Randomized trial comparing medical, economic and quality of life outcomes of non-primary PCI at hospitals with and without on-site cardiac.
Quality of Care and In-Hospital Outcomes in Patients With Coronary Heart Disease in Rural and Urban Hospitals (from Get With the Guidelines– Coronary.
STEMI Due to Stent Thrombosis: An Enlarging Subgroup of High Risk Patients Bruce Brodie, Adam Bensimhon, Nathan Fleishman, Charles Hansen, Mike Cooper,
Unrestricted Use of Drug-Eluting Stents Compared with Bare-Metal Stents in Routine Clinical Practice: Findings From the National Heart, Lung, and Blood.
Clinical Trial Results. org Pexelizumab for Acute ST-Elevation Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary Intervention.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
Validation of Mayo Clinic Risk Adjustment Model for In-Hospital Mortality following Percutaneous Coronary Interventions using the National Cardiovascular.
Published in Circulation 2005 Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery Disease: A Meta-Analysis Demosthenes.
Amr Hassan Mostafa, MD, FSCAI A. Professor of Cardiology Cairo University Cairo, Egypt Egypt Combat MI, March 24-25, Cairo Sheraton.
1 1 The Use of Percutaneous Coronary Intervention in Patients with Class I Indications for Coronary Artery Bypass Graft Surgery: Data from the National.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
Patterns of red blood cell transfusion use and outcomes in patients undergoing percutaneous coronary intervention in contemporary clinical practice: Insights.
Absence of Flow-Limiting Coronary Artery Disease Among Patients Undergoing Emergent Cardiac Catheterization For ST Segment Elevation Myocardial Infarction.
CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.
Ten-Year Follow-up Survival of the Medicine, Angioplasty, or Surgery Study (MASS-II): a Randomized Controlled Clinical Trial of Therapeutic Strategies.
Female Gender Is An Independent Predictor Of In-Hospital Mortality After STEMI In The Era of Primary PCI. Insights From The Greater Paris Area PCI Registry.
Tarunjit Singh Department of Internal Medicine Westchester Medical Center New York Medical College Valhalla NY.
Use of Arteriotomy Closure Devices and the Risk of Vascular Complications: An Analysis of 227,879 Patients in the NCDR Sameer K. Mehta MD, Andrew D. Frutkin.
A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery
Bleeding in Patients Undergoing Percutaneous Coronary Interventions: A Risk Model From 302,152 Patients in the NCDR. Sameer K. Mehta MD, Andrew D. Frutkin.
Treatment and Risk in Heart Failure: Gaps in Evidence or Quality? Pamela N. Peterson, MD MSPH; John S. Rumsfeld, MD PhD; Li Liang PhD; Adrian F. Hernandez,
Delays in Fibrinolytic Administration for Acute ST-Segment Elevation Myocardial Infarction: Results from the Acute Coronary Treatment and Interventions.
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
Presenter Disclosure Information DISCLOSURE INFORMATION: The following relationships exist related to this presentation Stock options None; Consults for.
The Impact of For-Profit Hospital Status on the Care and Outcomes of Patients with NSTEMI: Results From CRUSADE Bimal R. Shah, MD, Seth W. Glickman, MD,
Trends in the Quality of Care of Patients with Acute Myocardial Infarction: The National Registry of Myocardial Infarction from 1990 to 2006 Bimal R. Shah,
Impact of Prior Myocardial Infarction Among Patients with Acute Myocardial Infarction Treated in Contemporary Practice: A Report from the ACTION Registry.
Inter-Hospital Transfer of High Risk STEMI Patients for PCI is Safe and Feasible David M. Larson, Katie M. Menssen, Scott W. Sharkey, Marc C. Newell, Anil.
The Impact of For-Profit Hospital Status on the Care and Outcomes of Patients with NSTEMI: Results From CRUSADE Bimal R. Shah, MD, Seth W. Glickman, MD,
Bangalore S, et al. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012;308(13): ?
Is Veteran User Status an Independent Risk Factor for Mortality After Private Sector CABG? William B. Weeks, MD, MBA Dorothy A. Bazos, Ph.D. David M. Bott,
Antiplatelet Therapy Use after Discharge among Acute Myocardial Infarction Patients with In-hospital Bleeding Tracy Y. Wang, MD, MHS, Lan Xiao, PhD, Karen.
Is there any role for intravascular ultrasound in bifurcation lesions? Giuseppe Biondi-Zoccai, MD University of Turin, Turin, Italy.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Relationship Between Operator Volume and Adverse.
High-risk ST elevation MI patients (>4 mm elevation), Sx < 12 hrs 5 PCI centers (n=443) and 22 referring hospitals (n=1,129), transfer in < 3 hrs High-risk.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Smoking Is Associated With Adverse Clinical Outcomes.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Cardiovascular Surgery J Am Coll Cardiol.
CoRPS Center of Research on Psychology in Somatic diseases Brief Depression Screening with the PHQ-2 Predicts Poor Prognosis following PCI with Drug-Eluting.
Prof. Dr. Sigmund Silber, FESC, FACC On behalf of the RESOLUTE
Associate Professor, Honorary Consultant Cardiologist
Randomized vs. Observational Studies: Strengths and Weaknesses
A Clinical profile of patients enrolled in the Pakistan ACS registry
Talk Title SURGICAL BACK-UP IS NOT REQUIRED FOR PRIMARY PCI
Frequency of Percutaneous Coronary Interventions at Facilities Without On-Site Cardiac Surgical Backup—A Report from the American College of Cardiology–National.
On-Site Surgical Back-up is ‘Critically’ Important for PCI!
Debate: What Does the Future Hold for the Treatment of Unprotected Left Main Disease? More PCI No More Routine Surgery Ron Waksman, MD, FACC Washington.
Management of perioperative hypertension
Fibrinolytic therapy in hospitals without percutaneous coronary intervention capabilities in China from 2001 to 2011: China PEACE-retrospective AMI study.
Antiplatelet Therapy Use after Discharge among Acute Myocardial Infarction Patients with In-hospital Bleeding Tracy Y. Wang, MD, MHS, Lan Xiao, PhD, Karen.
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
Global Registry of Acute Coronary Events: GRACE
ACC/SCAI – i2 Summit Late Breaking Clinical Trials March 29, 2008
No Financial Disclosure or Conflict of Interest
Maintenance of Long-Term Clinical Benefit with
Atlantic Cardiovascular Patient Outcomes Research Team
Presentation transcript:

Percutaneous Coronary Interventions in Facilities without On-Site Cardiac Surgery: A Report from the National Cardiovascular Data Registry (NCDR) ACC/SCAI – i2 Summit Late Breaking Clinical Trials March 29, 2008

On Behalf of the National Cardiovascular Data Registry Michael A. Kutcher, MD Lloyd W. Klein, MD Thomas P. Wharton, Jr., MD Mandeep Singh, MD, MPH Gregory J. Dehmer, MD H. Vernon Anderson, MD John S. Rumsfeld, MD, PhD William S. Weintraub, MD Eric D. Peterson, MD, MPH Fang-Shu Ou, MS Sarah Milford-Beland, MS Al Woodward, PhD. MBA Ralph G. Brindis, MPH Wake Forest University Health Sciences Rush University School of Medicine Exeter Hospital, Exeter, NH Mayo Clinic Texas A&M School of Medicine Univ Texas Health Science, Houston Chief Science Officer, NCDR Christiana Health Care, Wilmington, DE Duke Clinical Research Institute (DCRI) DCRI NCDR Chief Executive Officer, NCDR

Special Thanks Jessica Morris Data Clarification Project Contact Staff Kristi Mitchell, MPH Data Clarification Project Coordinator NCDR and DCRI support staff Matthew Sacrinty, MS Wake Forest University Health Sciences  All the hospitals and their staff that have committed to participate in the NCDR

No Disclosures Related to this presentation

Background There are few published large studies that have examined whether the procedural outcomes at PCI facilities that do not have surgery on-site are as safe and effective compared to those facilities that have cardiac surgery on-site. Wennberg DE et al. JAMA 2004;292: Ting HH et al. J Am Coll Cardiol 2006;47: Carlsson J et al. SCARR. Heart 2007;93:335-8.

Background The National Cardiovascular Data Registry (NCDR) CathPCI Registry is a large ongoing multi-center database that offers a unique opportunity to provide contemporary insights into this controversial issue.  Standard data sets  Written definitions  Uniform data entry  Secure transmission requirements  Data quality and auditing checks  Risk adjustment algorithms

Study Population NCDR CathPCI Registry Consecutive PCI cases January 1, 2004 to March 30, ,161 patients 465 centers OFF-SITE Surgery Back-Up 9,029 patients 61 centers ON-SITE Surgery Back-up 299,132 patients 404 centers

Off-Site Data Clarification Project A Data Clarification (DC) Project was undertaken to address potentially ambiguous data issues unique to Off-Site PCI centers. Sites with questionable data were sent a Data Clarification Form (DCF) to clarify whether a patient “transferred for CABG” was elective or emergency and to verify eventual survival. An additional Off-Site Capabilities Survey (OSCS) was developed to gather information regarding organization, staffing, and logistics.

Off-Site Data Clarification Project Each Off-Site PCI program was formally contacted with follow-up by NCDR staff over a 4 month time period. 44 sites with 174 patients had data points that required verification. 38 sites (86%) were able to fill out the DCF to reconcile transfer and/or mortality data on 153 patients (88%). 49 out of 61 sites (80%) filled out the Off-Site Capabilities Survey (OSCS).

Statistical Analysis by DCRI Major endpoints  In-hospital death from all causes following PCI  Incidence of emergency surgery (version 3.04 definitions):  Emergency – CABG performed within <24 hours following PCI in which there was evidence of active ischemia or mechanical dysfunction.  Emergent/Salvage – patient required cardiopulmonary resuscitation en route to the OR or before anesthesia. Secondary endpoints  Cerebrovascular accident  Renal failure  Hemorrhage  Myocardial infarction  Reperfusion time in cases of primary PCI

Off-Site Capabilities Survey Transportation Logistics

Off-Site Capabilities Survey Organization and Staff

Institutional Characteristics * Two sites had missing CMS bed data

MI Presentation

Procedural Success and Complications

Observed Outcomes: All PCI Patients (P=0.3560) (P=0.8838)(P<.0001)

Risk Adjusted Outcomes Odds Ratio (OR): outcomes for patients at On-Site (vs. Off-Site) facilities Adjusting for site correlations and potential confounding variables

Limitations In-hospital outcomes were analyzed – long term follow-up was not available. Definitions did not discriminate whether emergency surgery was performed for complications of a PCI or whether PCI was a temporizing measure prior to staged surgery. Our study was based on a voluntary observational registry and a selection bias cannot be excluded.

Discussion Our study involves the largest clinical analysis and comparison of diverse PCI centers in the United States with and without on-site cardiac surgery support. The results of the Off-Site Capabilities Survey provides detailed information regarding the organization and logistics of the Off-Site PCI programs participating in the NCDR.

Conclusions Off-Site PCI centers participating in the NCDR are well organized with good logistical plans:  Dedicated staff and facilities.  Travel time, distances, and modality of transport are generally within range for timely transfer to the off-site surgery center.  92% of sites provide 24/7 coverage.  All sites are committed to provide primary PCI for STEMI.

Conclusions Compared to On-Site PCI centers, Off-Site PCI programs:  Have smaller bed capacities.  Are predominantly located in rural and suburban areas.  Have lower annual PCI volume.  Treat a higher percentage of patients who present with subsets of MI (STEMI and NSTEMI).  Have better reperfusion times in primary PCI.

Conclusions Compared to On-Site PCI centers, Off-Site PCI programs have similar observed:  Procedure success  Morbidity  Emergency CABG surgery rates  Mortality in cases that require emergency CABG The risk-adjusted mortality rate in Off-Site facilities was comparable to those PCI centers that have cardiac surgery on-site.

Implications Off-Site PCI centers can provide excellent care to patients – if the organization of the program is thoughtfully developed. The Off-Site programs in our study have demonstrated a strong commitment to key structure, process, and outcomes measurements. Without such a commitment, similar results may not be achievable.

Implications The findings of our study should not be extrapolated to encourage the wide-spread proliferation of Off-Site PCI programs. Our study does confirm the safety of an Off-Site strategy at existing PCI centers where rigorous clinical, operator, and institutional criteria are in place and are monitored to assure high quality outcomes.

Thank You

Backup Slides

Sensitivity Analysis Since there was some missing data for follow-up mortality that was not clarified, a sensitivity analysis was performed to assess the stability of the risk adjusted results. The analysis was comprised of 4 different models which imputed missing mortality to various potential scenarios.

Sensitivity Analysis * * ** *Worst case scenario – Patients with missing mortality were considered as all died **Best case scenario – Patients with missing mortality were considered as all alive

Sensitivity Analysis Although the Odds Ratio could change from 1.1 to 0.8, the sensitivity analysis of risk adjusted mortality for any of the 4 models was not statistically significant between Off-Site versus On-Site facilities. Based on these results, the missing data would not have significantly affected the stability or the conclusions of the risk adjusted model.

Statistical Analysis Data Analysis was performed by DCRI: To test for independence of a patient’s baseline characteristics, in-hospital care patterns and outcomes with respect to Off-Site vs. On-Site centers were analyzed. Mann-Whitney-Wilcoxon nonparametric tests were used for continuous variables. Pearson chi-square tests were used for categorical variables.

Statistical Analysis A multivariable logistic regression was utilized to estimate the association surgical status (On-Site versus Off-Site) and outcomes. The Generalized Estimate Equation (GEE) method was applied to account for within- hospital clustering, assuming patients at the same hospital are more likely to have similar responses relative to patients in other hospitals.

Variables in Risk Adjusted Mortality Model Age Gender Insulin treated diabetes Hypercholesterolemia Hypertension GFR/dialysis Cerebrovascular disease COPD PVD CHF Prior CABG Prior PCI Prior MI Cardiogenic shock MI presentation (STEMI, NSTEMI, no MI) Preoperative IABP PCI status (salvage, emergent, urgent, elective) Subacute thrombosis Treated left main lesion Treated total occlusion Treated lesion TIMI flow = 0 Treated lesion High/C Total number of lesions treated

Variables in Risk Adjusted Emergency Surgery Model Cardiogenic shock MI Presentation STEMI NSTEMI No MI Pre-operative IABP PCI status Salvage Emergent Urgent Elective Any treated left main lesion

Results

Patient Characteristics

Lesion Characteristics

Observed Outcomes: Primary PCI Patients (P=0.1213) (P=0.9439)(P=0.9195) (P=0.9833)

Background Since the introduction of PCI in 1977 by Andreas Gruntzig, a preferred practice has been to have cardiac surgery capabilities on-site to provide emergency CABG in the event of life threatening acute procedural failures.

Background Over the last 10 years, as a result of improvements in technology and pharmacology:  The incidence of emergency CABG surgery for failed PCI is now very infrequent ( %) Seshadri N et al. Circulation 2002;106: Yang EH et al. J Am Coll Cardiol 2005;  Primary PCI has been shown to be superior to fibrinolytic therapy for the treatment of STEMI Keely et al. Lancet 2003;361:13-20.

Background These developments have formed the justification for some hospitals without on-site cardiac surgery to develop PCI programs based on a strategy to:  Provide more rapid and superior care for STEMI in the form of primary PCI  Increase the availability of primary and elective PCI to patients residing in geographically underserved areas.

Background The safety and efficacy of performing primary PCI in facilities without on site surgical back-up has been documented in several trials. Wharton TP Jr. et al. J Am Coll Cardiol 1999;33: Aversano T el. C-PORT trial. JAMA 2002;287: Wharton TP Jr. et al. PAMI-NoSOS Study. J Am Coll Cardiol 2004;43: There have been numerous observational reports that extend the Off-Site concept to both primary and elective PCI.

Background The ACC/AHA/SCAI 2005 PCI Guidelines designated the following indications for PCI at centers that do not have surgery on-site:  Primary PCI – Class IIb “may be considered”  Elective PCI – Class III “not recommended” Smith SC Jr. et al. J Am Coll Cardiol 2006;47: The 2007 Focused PCI Guideline Update did not address or change these designations. King SB III et al. J Am Coll Cardiol 2008;51: